...
首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Preliminary investigations of the colonisation of upper respiratory tract tissues of infants using a paediatric formulation of the oral probiotic Streptococcus salivarius K12.
【24h】

Preliminary investigations of the colonisation of upper respiratory tract tissues of infants using a paediatric formulation of the oral probiotic Streptococcus salivarius K12.

机译:使用口服益生菌唾液链球菌K12的儿科配方对婴儿的上呼吸道组织定植的初步研究。

获取原文
获取原文并翻译 | 示例
           

摘要

A powder preparation of the oral probiotic Streptococcus salivarius K12 has been given to 19 young otitis media-prone children following a 3-day course of amoxicillin administered as a preliminary to ventilation tube placement. In two subjects, the use of strain K12 appeared to effect the expansion of an indigenous population of inhibitory S. salivarius. In other children, strain K12 colonisation extended beyond the oral cavity to also include the nasopharynx or adenoid tissue. The relatively low proportion (33%) of subjects that colonised was attributed to failure of the amoxicillin pre-treatment to sufficiently reduce the indigenous S. salivarius populations prior to dosing with strain K12 powder.
机译:口服益生菌唾液链球菌K12的粉末制剂已在19天易患中耳炎的儿童中接受了为期3天的阿莫西林疗程,作为通气管放置的初步方法。在两个受试者中,菌株K12的使用似乎影响了抑制唾液链球菌的本地种群的扩展。在其他儿童中,菌株K12的定殖延伸到了口腔之外,还包括鼻咽或腺样体组织。相对较低的比例(33%)被定植的受试者归因于阿莫西林预处理未能在用菌株K12粉末给药之前充分减少唾液链球菌的种群。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号